IVOSIDENIB for Bone cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where IVOSIDENIB was used for Bone cancer.
Most Reported Side Effects for IVOSIDENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 613 | 36.2% | 31 | 96 |
| Fatigue | 144 | 8.5% | 6 | 17 |
| Diarrhoea | 100 | 5.9% | 4 | 17 |
| Nausea | 100 | 5.9% | 5 | 27 |
| Disease progression | 86 | 5.1% | 19 | 9 |
| Differentiation syndrome | 80 | 4.7% | 22 | 46 |
| Product dose omission issue | 68 | 4.0% | 0 | 16 |
| Drug ineffective | 64 | 3.8% | 12 | 13 |
| Platelet count decreased | 61 | 3.6% | 3 | 27 |
| Electrocardiogram qt prolonged | 58 | 3.4% | 3 | 19 |
| Pneumonia | 51 | 3.0% | 9 | 40 |
| Vomiting | 51 | 3.0% | 4 | 26 |
| Asthenia | 49 | 2.9% | 6 | 17 |
| Febrile neutropenia | 48 | 2.8% | 7 | 43 |
| Product use issue | 43 | 2.5% | 4 | 13 |
Other Indications for IVOSIDENIB
Acute myeloid leukaemia (729)
Cholangiocarcinoma (277)
Product used for unknown indication (194)
Brain neoplasm malignant (140)
Myelodysplastic syndrome (65)
Off label use (27)
Astrocytoma (20)
Glioma (16)
Bile duct cancer (15)
Acute leukaemia (13)
Other Drugs Used for Bone cancer
PALBOCICLIB (493)
LENALIDOMIDE (342)
CABOZANTINIB S-MALATE (328)
DENOSUMAB (219)
ENZALUTAMIDE (213)
PAZOPANIB (182)
ERLOTINIB (174)
CAPECITABINE (143)
BEVACIZUMAB (140)
POMALIDOMIDE (114)